HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$3.18
Day range
$3.08 - $3.42
Year range
$2.66 - $18.07
Market cap
229.68M USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 51.43M | -17.99% |
Net income | -40.16M | 27.68% |
Net profit margin | — | — |
Earnings per share | -0.56 | 29.11% |
EBITDA | -51.11M | 18.05% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 391.25M | -24.27% |
Total assets | 450.66M | -23.06% |
Total liabilities | 96.33M | -7.21% |
Total equity | 354.33M | — |
Shares outstanding | 71.27M | — |
Price to book | 0.64 | — |
Return on assets | -27.29% | — |
Return on capital | -31.20% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -40.16M | 27.68% |
Cash from operations | -44.04M | -13.91% |
Cash from investing | 48.24M | 141.08% |
Cash from financing | 92.00K | -70.23% |
Net change in cash | 4.29M | 102.75% |
Free cash flow | -29.16M | -56.04% |
About
Founded
2014
Website
Employees
124
